Induced pluripotent stem cells: Methods, disease modeling, and microenvironment for drug discovery and screening

The raging ethical, religious, moral, political, and safety issues pertaining to the use of embryonic stem cells for therapy and research have prompted researchers to develop possibly better alternatives that are more efficacious and serve multiple purposes. | Turkish Journal of Biology Review Article Turk J Biol (2016) 40: 998-1011 © TÜBİTAK doi: Induced pluripotent stem cells: methods, disease modeling, and microenvironment for drug discovery and screening Suresh Palamadai KRISHNAN* School of Biosciences and Technology, Vellore Institute of Technology (VIT University), Vellore, Tamil Nadu, India Received: Accepted/Published Online: Final Version: Abstract: The raging ethical, religious, moral, political, and safety issues pertaining to the use of embryonic stem cells for therapy and research have prompted researchers to develop possibly better alternatives that are more efficacious and serve multiple purposes. Induced pluripotent stem cells (iPSCs) developed by multiple methods provide an unparalleled source of cells that could be differentiated into progeny cells. In cell-based disease models the progeny cells mimic, at least in part, the pathology of the studied disease and are used to improve the mechanistic understanding of the pathology. Furthermore, these cells could be used to test the efficacy and safety of drugs that can reverse this phenotype. This review provides an overview of the aforesaid methods for iPSC generation and the development of certain disease-based model systems. In this review, the focus is on model systems for neurological and hematological diseases. Last but not least, the importance of the microenvironment is underscored and the significance of these model systems is discussed in the context of drug screening and development. Key words: Induced pluripotent stem cells, reprogramming methods, integrating/nonintegrating, induced pluripotent stem cell disease models, neurological/hematological diseases, induced pluripotent stem cell microenvironment modeling, drug discovery/screening 1. Introduction There are raging ethical, religious, moral, political, and safety issues pertaining to the use of

Không thể tạo bản xem trước, hãy bấm tải xuống
TỪ KHÓA LIÊN QUAN
TÀI LIỆU MỚI ĐĂNG
12    20    1    24-11-2024
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.